The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.

For the first time in nearly 50 years, the New York Yankees are allowing players to grow “well-groomed beards.”

It extends a tumultuous period for UnitedHealth marked by the killing of a top executive, a costly cyberattack against its subsidiary and high medical costs.

Rivian beat Wall Street’s fourth-quarter earnings expectations and achieved its first gross quarterly profit but is forecasting lower sales in 2025.

President Trump has expressed frustration about delays of new Air Force One aircraft from Boeing.

ESPN plans to add user-generated content features in its upcoming streaming application, which will cost either $25 or $30 per month, sources say.

Amazon reached a deal with the Broccoli family, the James Bond franchise’s longstanding producers, to form a new joint venture.

Toy and gaming giant Hasbro is shifting manufacturing away from China as it eyes the impact of U.S. tariffs.

Eli Lilly wants to take big swings in Alzheimer’s, ALS, chronic pain and other difficult diseases after its success in obesity.

Eli Lilly Chief Scientific Officer Dan Skovronsky spoke to CNBC about obesity pills and more on the future of weight loss.